Get the Stockscreener App
5.3302
0.19%
-0.0298
Abeona Therapeutics Inc stock is traded at $5.3302, with a volume of 157.10K.
It is down -0.19% in the last 24 hours and down -16.80% over the past month.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
See More
Previous Close:
$5.36
Open:
$5.47
24h Volume:
157.10K
Relative Volume:
0.19
Market Cap:
$274.34M
Revenue:
-
Net Income/Loss:
$-54.19M
P/E Ratio:
-2.066
EPS:
-2.58
Net Cash Flow:
$-37.34M
1W Performance:
+0.19%
1M Performance:
-16.80%
6M Performance:
+16.30%
1Y Performance:
-16.54%
1-Day Range:
$5.34
$5.47
1-Week Range:
$5.215
$5.73
52-Week Range:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Name
Abeona Therapeutics Inc
Sector
Industry
Phone
646-813-4701
Address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.35 | 274.85M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.42 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.45 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.17 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.67 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Mar-05-25 | Initiated | Oppenheimer | Outperform |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| May-30-24 | Initiated | Stifel | Buy |
| Nov-11-20 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-18-20 | Initiated | B. Riley FBR | Buy |
| Feb-10-20 | Initiated | SVB Leerink | Outperform |
| Dec-10-19 | Resumed | Cantor Fitzgerald | Neutral |
| Aug-15-19 | Downgrade | Maxim Group | Buy → Hold |
| Aug-12-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-26-19 | Downgrade | Mizuho | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Oct-12-18 | Initiated | Mizuho | Buy |
| Jun-05-18 | Initiated | Seaport Global Securities | Buy |
| Nov-08-17 | Initiated | SunTrust | Buy |
| Oct-16-17 | Reiterated | H.C. Wainwright | Buy |
| Oct-11-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Oct-10-17 | Initiated | Citigroup | Buy |
| Oct-05-17 | Reiterated | Maxim Group | Buy |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Jul-18-17 | Reiterated | Maxim Group | Buy |
| Jun-22-17 | Resumed | Jefferies | Buy |
| Jan-06-17 | Initiated | Jefferies | Buy |
| Sep-29-16 | Reiterated | Maxim Group | Buy |
View All
Abeona Therapeutics Inc Stock (ABEO) Latest News
Why Abeona Therapeutics Inc. is moving todayDollar Strength & Real-Time Buy Signal Alerts - newser.com
Abeona Therapeutics Inc. stock daily chart insightsWeekly Earnings Recap & Fast Entry Momentum Alerts - newser.com
3 Top Growth Stocks Insiders Are Eager To Hold - Yahoo Finance
Abeona Therapeutics Inc. stock trend forecastEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Is Abeona Therapeutics Inc. (PCJ) stock a top dividend aristocrat candidate2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Will Abeona Therapeutics Inc. (PCJ) stock benefit from Fed rate cutsMarket Sentiment Summary & Verified Technical Trade Signals - newser.com
Is Abeona Therapeutics Inc a good long term investmentWeekly Market Snapshot & Small Entry Portfolio - earlytimes.in
Is Abeona Therapeutics Inc. (PCJ) stock a good hedge against inflationTake Profit & Growth Oriented Trade Recommendations - newser.com
What drives Abeona Therapeutics Inc stock priceMoving Average Crossovers & Free High Margin Investment Plays - earlytimes.in
Abeona Therapeutics' (ABEO) "Hold (C-)" Rating Reiterated at Weiss Ratings - MarketBeat
Abeona Therapeutics (ABEO) Expands Treatment Options for RDEB Pa - GuruFocus
Abeona Therapeutics and Children's Hospital Colorado Activate New Center for ZEVASKYN Treatment of Recessive Dystrophic Epidermolysis Bullosa - Quiver Quantitative
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy - The Manila Times
Abeona Therapeutics® and Children's Hospital Colorado - GlobeNewswire
Children's Hospital Colorado named newest QTC for Abeona's FDA‑approved ZEVASKYN to treat RDEB - Stock Titan
What analysts say about Abeona Therapeutics Inc PCJ stockPrice Volatility Patterns & Outstanding Return Stocks - earlytimes.in
What drives Abeona Therapeutics Inc PCJ stock priceDividend Cut Warnings & Low Cost Capital Trading - earlytimes.in
Will Abeona's Gene Therapy For Dystrophic Epidermolysis Bullosa Achieve Wider Adoption? - RTTNews
Abeona Therapeutics Inc Stock Analysis and ForecastBull Market Opportunities & Small Budget Capital Investment - earlytimes.in
Analyzing drawdowns of Abeona Therapeutics Inc. with statistical tools2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Market reaction to Abeona Therapeutics Inc.’s recent newsQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
What’s next for Abeona Therapeutics Inc. stock priceJuly 2025 Fed Impact & Daily Stock Trend Reports - newser.com
Analyzing recovery setups for Abeona Therapeutics Inc. investorsQuarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com
Understanding Abeona Therapeutics Inc.’s price movementIPO Watch & Short-Term Swing Trade Alerts - newser.com
Why Abeona Therapeutics Inc. (PCJ) stock attracts HNW investorsJuly 2025 Retail & Technical Pattern Alert System - newser.com
Can Abeona Therapeutics Inc. stock sustain free cash flow growthMarket Risk Analysis & Short-Term Trading Alerts - newser.com
Order flow analysis tools used on Abeona Therapeutics Inc.July 2025 Trade Ideas & Community Verified Trade Alerts - newser.com
Will Abeona Therapeutics Inc. stock maintain momentum in 2025Trade Analysis Summary & Weekly Market Pulse Updates - newser.com
What analysts say about Abeona Therapeutics Inc stockVolatility Adjusted Trading & Fast Profit Stock Ideas - earlytimes.in
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Abeona Therapeutics (ABEO) Grants Equity Awards to New Employees - GuruFocus
BRIEF-Abeona Therapeutics Announces New Employee Inducement - The Sunday Guardian
Abeona Therapeutics announces new employee inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Abeona Therapeutics Inc Stock (ABEO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Abeona Therapeutics Inc Stock (ABEO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Seshadri Vishwas | Chief Executive Officer |
Sep 30 '25 |
Sale |
5.24 |
25,000 |
130,930 |
1,190,067 |
| Seshadri Vishwas | Chief Executive Officer |
Sep 29 '25 |
Sale |
5.39 |
19,274 |
103,954 |
1,215,067 |
| Vazzano Joseph Walter | Chief Financial Officer |
Sep 29 '25 |
Sale |
5.39 |
9,035 |
48,730 |
453,631 |
2.20%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):